scispace - formally typeset
P

Pankaj J. Pasricha

Researcher at Johns Hopkins University

Publications -  460
Citations -  20695

Pankaj J. Pasricha is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Gastroparesis & Gastric emptying. The author has an hindex of 69, co-authored 427 publications receiving 17988 citations. Previous affiliations of Pankaj J. Pasricha include Johns Hopkins University School of Medicine & University of Texas Medical Branch.

Papers
More filters
Journal ArticleDOI

Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.

TL;DR: This study supports the Braak hypothesis in the etiology of idiopathic Parkinson's disease by assessing α- synucleinopathy in the brain in a novel gut-to-brain α-syn transmission mouse model, where pathologicalα-syn preformed fibrils were injected into the duodenal and pyloric muscularis layer.
Journal ArticleDOI

A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development.

TL;DR: In this paper, the abdominal withdrawal reflex and responses of viscerosensitive neurons were recorded during colon distention in a rat with either mechanical or chemical colonic irritation between postnatal days 8 and 21 and were tested when they became adults.
Journal Article

Inhibition of apoptosis during development of colorectal cancer.

TL;DR: This data indicates that the transformation of colorectal epithelium to carcinomas was associated with a progressive inhibition of apoptosis, which may contribute to tumor growth, promote neoplastic progression, and confer resistance to cytotoxic anticancer agents.
Journal ArticleDOI

Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease

TL;DR: Experimental validation that an antiulcer drug and an antiepileptic can be reused for lung cancer and inflammatory bowel disease reinforces the promise of the computational approach to discover new drug therapies for IBD in silico.